Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Venlafaxine Hydrochloride Sustained-Release Capsules

Approval Number

国药准字HJ20160384

CompanyUpJohn US 2 LLC

Registration Date

July 22, 2021

Previous Approval Numbers

H20160384

Drug Information

Generic Name

盐酸文拉法辛缓释胶囊

Trade Name

怡诺思

Dosage Form

胶囊剂

Strength

150mg（以文拉法辛计）

Drug Type

化学药品

Registration Date

July 22, 2021

Expiry Date

July 21, 2026

Company Information

Applicant Company

Company NameUpJohn US 2 LLC

Company Address

3711 Collins Ferry Road, Morgantown, WV 26505 United States of America

Manufacturing Company

Company NamePfizer Ireland Pharmaceuticals

Company Address

Little Connell, Newbridge, Co Kildare, Ireland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy